Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation (XANTUS)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: May 24, 2012
Last updated: July 22, 2016
Last verified: May 2016